HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ingrid M Bistervels Selected Research

Ingrid M Bistervels Research Topics

Disease

6Venous Thrombosis (Deep-Vein Thrombosis)
01/2023 - 01/2018
4Venous Thromboembolism
11/2022 - 11/2018
4Hemorrhage
01/2022 - 01/2019
3Pulmonary Embolism
07/2021 - 11/2018
2Postthrombotic Syndrome
07/2022 - 11/2018
1Frailty
01/2022
1Fetal Death
01/2022
1Thrombosis (Thrombus)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Pregnancy Complications
01/2019
1Thromboembolism
01/2019
1Uterine Hemorrhage (Uterine Bleeding)
01/2019
1Hemoptysis
01/2019
1Pre-Eclampsia (Preeclampsia)
01/2019
1Subacute Sclerosing Panencephalitis (SSPE)
11/2018
1Venous Insufficiency
01/2018

Drug/Important Bio-Agent (IBA)

3AnticoagulantsIBA
01/2022 - 01/2019
2edoxabanIBA
07/2022 - 07/2021
2Warfarin (Coumadin)FDA LinkGeneric
07/2022 - 07/2021
2RivaroxabanIBA
01/2022 - 01/2022
2Vitamin KFDA Link
01/2022 - 01/2022
2fibrin fragment D (D-dimer)IBA
01/2019 - 11/2018
1cupric sulfide (CuS)IBA
01/2023
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2022
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022
1Cytochrome P-450 CYP3AIBA
01/2022
1Hemostatics (Antihemorrhagics)IBA
01/2019
1Tranexamic Acid (AMCA)FDA Link
01/2019
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
11/2018

Therapy/Procedure

3Therapeutics
01/2019 - 01/2018
2Polypharmacy
01/2022 - 01/2022
2Duration of Therapy
11/2018 - 01/2018
1Contraindications
01/2022
1Vena Cava Filters (Inferior Vena Cava Filter)
01/2022
1Compression Stockings
01/2018